Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193805-24-000772
Filing Date
2024-06-10
Accepted
2024-06-10 16:05:34
Documents
4

Document Format Files

Seq Description Document Type Size
1 e663697_424b5-immunic.htm 424B5 350875
2 GRAPHIC image_001.jpg GRAPHIC 3926
3 GRAPHIC image_002.jpg GRAPHIC 21220
4 GRAPHIC image_004.jpg GRAPHIC 28021
  Complete submission text file 0001193805-24-000772.txt   425613
Mailing Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036
Business Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036 (332) 255-9818
IMMUNIC, INC. (Filer) CIK: 0001280776 (see all company filings)

EIN.: 562358443 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-275717 | Film No.: 241032682
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)